Has Travis King received payments from drug or device companies?

Yes. Drug and device makers reported $1,856 in general payments to Travis King across 46 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Travis King did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Travis King come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Travis King

Acute Care · New Orleans, LANPI 1659904407

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,527 of the $1,856 with a category attached, or 82.3%. It is spread thinly across 21 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $648, 5.4 times the $121 reported in 2021.

$1,856in general payments, 2019–2025

Across 46 payments — averaging $40.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Invivyd Inc$299
Melinta Therapeutics, LLC$281
La Jolla Pharmaceutical Company$187
Merck$184
Medtronic$170
Boston Scientific$144
plus $589 from 15 others

What the payments were for

Speaking & faculty fees$28115%
Travel & lodging$473%
Food & beverage$1,52782%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Invivyd Inc	2	$299
Melinta Therapeutics, LLC	1	$281
La Jolla Pharmaceutical Company	3	$187
Merck	10	$184
Medtronic	4	$170
Boston Scientific	3	$144
Baxter Healthcare	1	$120
Abiomed	2	$72
Chiesi USA, Inc.	3	$55
Novo Nordisk	2	$51
Lexicon Pharmaceuticals, Inc.	2	$44
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$43
Aimmune Therapeutics, Inc.	1	$34
Kestra Medical Technology Services, Inc.	2	$34
Boehringer Ingelheim	2	$29
Acist Medical Systems, Inc.	1	$26
Pfizer	1	$19
Lilly USA, LLC	1	$18
Terumo Medical Corporation	1	$15
ALON Medical Technology	1	$15
BTG International Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,856 in reported general payments places this provider in the 75th percentile of 248 acute care providers in Louisiana.

See all acute care providers in Louisiana →

Medicare billing

Part B allowed, 2024

$6,564

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EntrestoSacubitril/Valsartan	14	$11,270
Amiodarone Hcl	27	$975
Metoprolol Succinate	38	$584
ClopidogrelClopidogrel Bisulfate	55	$472
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	61	$423
Metoprolol Tartrate	27	$253
Potassium Chloride	16	$176
Amlodipine Besylate	12	$120
Warfarin Sodium	20	$115
Furosemide	26	$95
Ciprofloxacin Hcl	11	$66
Oxycodone Hcl	17	$62

Paid to pharmacies, not to this prescriber.

Other acute care in New Orleans

Charles JarreauNew Orleans$40K
Anita RichardNew Orleans$7K
Candita ThompsonNew Orleans$2K
Erica LoveNew Orleans$2K
Annie StadstadNew Orleans$2K
Jennifer FlemingNew Orleans$2K
Precious HodgesLafayette$70K
Brinton FegleyShreveport$61K
Jeremy DavisShreveport$35K
Heather MecomShreveport$17K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →